Guardant Health Inc (GH) Stock Forecast & Price Target
Guardant Health Inc · NASDAQ
$143.51-1.96 (-1.35%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 23 firms covering Guardant Health Inc, 23 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $110.00 to $215.00, a moderate spread. The average target of $164.52 sits 15% above the current $143.51. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 19 to 21 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.30 next quarter toward $-0.43 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS23 ratings
Moderate Buy
Strong Buy00%
Buy23100%
Hold00%
Sell00%
Strong Sell00%
Based on 23 analysts giving stock ratings to Guardant Health Inc.
As of Jul, 21 of 21 firms rate GH a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
GH EPS & revenue forecast
EPS · NEXT QUARTER
$-0.30
Range $-0.36 – $-0.26 · 17 analysts · -23% YoY
Next period, 17 analysts expect Guardant Health Inc to earn $-0.30 a share (range $-0.36 – $-0.26), versus $-0.39 a year earlier. Full-year consensus is $-1.39, growing to $-0.43 the year after.
REVENUE · NEXT QUARTER
$338.8M
Range $331.7M – $345.0M · 17 analysts · +28% YoY
Revenue is expected to reach $338.8M (range $331.7M – $345.0M), +27.7% year-over-year. Full-year consensus is $1.3B, rising to $1.7B next year.
Top analysts covering Guardant Health Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on GH.
#1
KM
Kyle Mikson
Canaccord Genuity · Rank #192
Buy
$205.00+42.8% to target
Overall win rate
35%
+ Follow
#2
Luke Sergott
Barclays · Rank #194
Buy
$150.00+4.5% to target
Overall win rate
41%
+ Follow
#3
SJ
Sung Ji Nam
Scotiabank · Rank #196
Buy
$60.00-58.2% to target
Overall win rate
45%
+ Follow
#4
David Westenberg
Piper Sandler · Rank #227
Buy
$135.00-5.9% to target
Overall win rate
31%
+ Follow
#5
Patrick Donnelly
Citigroup · Rank #260
Buy
$215.00+49.8% to target
Overall win rate
32%
+ Follow
GH stock forecast FAQ
What is GH's average 12-month price target?+
The 21 analysts with a live target average $164.52 for Guardant Health Inc over the next 12 months, ranging from a $215.00 high to a $110.00 low.
Is GH stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 23 analyst ratings, 23 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for GH?+
The Street-high target is $215.00 (Citigroup), and the Street-low is $110.00 (UBS). The average of all 21 active targets is $164.52.
How many Wall Street analysts cover GH?+
23 analysts have an active rating on Guardant Health Inc, and 21 firms carry a live 12-month price target.
Who is the most accurate analyst covering GH?+
Among analysts who currently cover GH, Kyle Mikson of Canaccord Genuity has the strongest overall Quantellect track record (Rank #192). Their current call is Buy with a $205.00 target.
What is Guardant Health Inc's projected EPS for next quarter?+
The consensus estimate is $-0.30 per share (range $-0.36 – $-0.26) across 17 analysts. Full-year EPS is projected at $-1.39, rising to $-0.43 the following year.
How much revenue is Guardant Health Inc expected to report next quarter?+
Consensus revenue is $338.8M (range $331.7M – $345.0M). Full-year revenue is projected at $1.3B, growing to $1.7B next year.
Have analysts been upgrading or downgrading GH lately?+
As of Jul, 21 of 21 firms rate GH a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their GH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
